Table 1 Patient characteristics
No. | [%] | |
|---|---|---|
Total | 157 | 100 |
Sex | ||
Male/Female | 94/63 | 60/40 |
Age, years | ||
median (range) | 59 · 0 (34–74) | |
Primary tumor and lymph node classification | ||
cT1-3 N2 | 81 | 52 |
cT1-3 N3 | 35 | 22 |
cT4 N2 | 37 | 24 |
cT4 N3 | 4 | 2 |
Histology | ||
Squamous Cell Carcinoma | 58 | 37 |
Adenocarcinoma | 75 | 48 |
Large Cell Carcinoma | 16 | 10 |
not differentiated, NOS | 7 | 4 |
sarcomatoid | 1 | 1 |
G | ||
1 | 3 | 2 |
2 | 50 | 32 |
3 | 94 | 60 |
x | 10 | 6 |
Localisation | ||
Sulcus Superior (Pancoast) | 9 | 6 |
Upper Lobe | 95 | 60 |
Middle Lobe/Centrally located | 30 | 19 |
Lower Lobe | 23 | 15 |
Induction Chemotherapy | ||
Cisplatin/Etoposide | 11 | 7 |
Cisplatin/Paclitaxel | 146 | 93 |
Concurrent Chemotherapy | ||
Cisplatin/Etoposide | 28 | 18 |
Cisplatin/Vinorelbine | 129 | 82 |
Radiotherapy Fractionation | ||
conventional | 77 | 49 |
accelerated-hyperfractionated | 80 | 51 |
Surgery | ||
Segmentectomy | 2 | 1 |
Lobectomy | 105 | 68 |
Bi-Lobectomy | 7 | 4 |
Pneumonectomy | 40 | 26 |
Thoracotomy without resection | 1 | 1 |
Resection | ||
microscopic complete (R0) | 143 | 92 |
microscopic incomplete (R1) | 9 | 6 |
macroscopic incomplete (R2) | 4 | 2 |